About
Healionics is addressing the critical need for safer, more reliable means of bloodstream access to perform dialysis in patients with kidney failure. Our STARgraft vascular graft (synthetic blood vessel) is designed to resist the problems of occlusion and infection suffered by current devices. We also have an exciting product pipeline based on our platform STAR® biomaterial, which has a unique ability to prevent two serious problems that affect all implantable devices: scarring and infection. The company is currently conducting human studies of STARgraft and has 36 patents issued or pending.
Technologies
OutlookGoogle Cloud HostingMobile FriendlyNginxWordPress.orgRemoteSisenseAIWebmailDomoKNIME
Keywords
biotechnologylife sciencesbiocompatibilitybioresistancetissue regenerationinfection resistancefda breakthrough devicehealthcare equipment & suppliesbiointegrationsphere templated angiogenic regenerationimplantable devicesmedical equipment and supplies manufacturingvascular graftmedical devicetissue healingbiomaterialsangiogenesisbiointegration technologystar platformmedical devicesnanobiotechnologywound healing scaffoldsdialysis accessregenerative medicinestargraftbiomaterial scaffoldinvestigational deviceporous biomaterialsvascular access devicesb2b
Company Information
- Employees10
- Founded2007
- Annual Revenue$4000000
- Total Funding$34433115
Location
2121 N 35th St, Seattle, Washington, United States, 98103-9103
